Literature DB >> 3654954

Problems in identification of Campylobacter jejuni associated with acquisition of resistance to nalidixic acid.

M Altwegg1, A Burnens, J Zollinger-Iten, J L Penner.   

Abstract

In a patient with campylobacteriosis, we observed development of resistance to nalidixic acid and norfloxacin under adequate treatment with the latter antibiotic. Isolates before and after treatment differed in their total protein profile but were otherwise identical with respect to enzymatic activity, serotype, crude membrane protein profiles, and other phenotypic characteristics.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3654954      PMCID： PMC269340          DOI： 10.1128/jcm.25.9.1807-1808.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Rapid hippurate hydrolysis method for presumptive identification of group B streptococci.

Authors:  M N Hwang; G M Ederer
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

2.  Mixed infections with different species and serotypes of Campylobacter.

Authors:  A J Lastovica; E Le Roux; J L Penner
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

3.  [Resistance patterns in Shigella].

Authors:  M Altwegg
Journal:  Schweiz Med Wochenschr       Date:  1986-12-27

4.  Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.

Authors:  F Rogerie; D Ott; J Vandepitte; L Verbist; P Lemmens; I Habiyaremye
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

Review 5.  Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; R N Brogden; D M Richards
Journal:  Drugs       Date:  1985-12       Impact factor: 9.546

6.  Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens.

Authors:  J L Penner; J N Hennessy; R V Congi
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

7.  Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents.

Authors:  L A Lariviere; C L Gaudreau; F F Turgeon
Journal:  J Antimicrob Chemother       Date:  1986-12       Impact factor: 5.790
  7 in total
  13 in total

1.  Campylobacter insulaenigrae isolates from northern elephant seals (Mirounga angustirostris) in California.

Authors:  Robyn A Stoddard; William G Miller; Janet E Foley; Judy Lawrence; Frances M D Gulland; Patricia A Conrad; Barbara A Byrne
Journal:  Appl Environ Microbiol       Date:  2007-01-26       Impact factor: 4.792

2.  Evaluation of the indoxyl acetate hydrolysis test for the differentiation of Campylobacters.

Authors:  D S Hodge; A Borczyk; L L Wat
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  Identification and classification of Campylobacter strains by using nonradioactive DNA probes.

Authors:  D Chevrier; D Larzul; F Megraud; J L Guesdon
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

Review 4.  The genus Campylobacter: a decade of progress.

Authors:  J L Penner
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

5.  Restriction fragment length polymorphisms in the ribosomal genes for species identification and subtyping of aerotolerant Campylobacter species.

Authors:  J A Kiehlbauch; B D Plikaytis; B Swaminathan; D N Cameron; I K Wachsmuth
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

6.  Evaluation of the API-campy system in the biochemical identification of hippurate negative campylobacter strains isolated from faeces.

Authors:  J Reina; M J Ros; A Serra
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

7.  Bias of phenotypic techniques for identification of Campylobacter isolates.

Authors:  P Matsiota-Bernard; D Chevrier; C Nauciel; J Guesdor
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

8.  Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin.

Authors:  H Adler-Mosca; J Lüthy-Hottenstein; G Martinetti Lucchini; A Burnens; M Altwegg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

Review 9.  Use of quinolones in the treatment of gastrointestinal infections.

Authors:  H L DuPont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 10.  Quinolones and the gastrointestinal tract.

Authors:  B E Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.